Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 11Uterine Cervical Dysplasia 4Papillomavirus Infections 2Ovarian Neoplasms 2Neoplasms 2Uterine Neoplasms 1Precancerous Conditions 1Ovarian Diseases 1HIV Infections 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Carboplatin 44Paclitaxel 41Cyclophosphamide 21Topotecan 19Cisplatin 18Peripheral Blood Stem Cell Transplantation 15Filgrastim 15Docetaxel 15Gemcitabine 13Bevacizumab 13liposomal doxorubicin 11Hyperthermic Intraperitoneal Chemotherapy 11sargramostim 9Therapeutics 8Immunohistochemistry 8Psychiatric Rehabilitation 7Drug Therapy 7Amifostine 7pembrolizumab 6olaparib 6Taxes 6Surveys and Questionnaires 6Melphalan 6Flow Cytometry 6Early Intervention, Educational 6Chemotherapy, Adjuvant 6niraparib 5denileukin diftitox 5Surgical Procedures, Operative 5Immunoenzyme Techniques 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Ovarian Epithelial × Papanicolaou Test × Clear all
NCT04794322 2025-09-16

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Massachusetts General Hospital

Recruiting
250 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Ovarian Diseases, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡